ロード中...
CSIG-24. miR-575 IS ASSOCIATED WITH WORSE SURVIVAL OF GBM PATIENTS AND ACTS AS A NOVEL ONCOGENE THROUGH TARGETING p27/CDKN1B AND BLID/BRCC2
Glioblastoma (GBM) patients currently face poor survival outcomes with an average survival period of less than 15 months, while only 3–5% of patients survive longer than 36 months. Although the mechanisms of tumorigenesis are still being elucidated, miRNAs are promising candidates to explore as nove...
保存先:
| 出版年: | Neuro Oncol |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216672/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.190 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|